Market Tracker

12/08 3:04pm ET

SPDR® S&P Biotech ETF (XBI)

61.42
BATS BZX Real-Time Price
As of 3:04pm ET
 -0.37 / -0.60%
Today’s Change
44.16
Today|||52-Week Range
71.87
-12.51%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+7.66% 3 years+13.81%
3 months-1.52% 5 years+24.08%
1 year-8.19% Since inception+13.34%
Data through 12/08/2016

Quote Details

Previous close$61.79
Open day’s range60.41 – 61.70
Net asset value (NAV)61.75 (12/07/2016)
Daily volume518,042
Average volume (3 months)6,796,882
Data as of 3:04pm ET, 12/08/2016

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+24.08%+20.19%
Expense Gross exp ratio0.35%1.31%
Risk 5 year sharpe ratio0.851.11
Net assets$3.1B$2.9B
Average market cap$4.8B$31.6B
Average P/E--18.6
Dividend / Share--0.26%

Competitors

XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc3.65%
TSRO TESARO Inc3.59%
INCY Incyte Corp3.13%
EXEL Exelixis Inc3.10%
SRPT Sarepta Therapeutics Inc3.05%
CELG Celgene2.75%
UTHR United Therapeutics Corp2.54%
RARE Ultragenyx Pharmaceutical Inc2.53%
ARIA ARIAD Pharmaceuticals Inc2.44%
BLUE bluebird bio Inc2.41%